New pill could boost testosterone in men with kidney disease
NCT ID NCT05249634
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests an oral testosterone pill called JATENZO in 20 men who have both low testosterone and chronic kidney disease. The goal is to see if the pill can raise testosterone levels and improve red blood cell counts, muscle strength, lean body mass, and sexual function. Participants take the pill daily for several weeks, and researchers monitor their blood and overall health.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
JATENZO (oral testosterone)
What this could lead to
If successful, this could offer a convenient oral treatment option for low testosterone in men with chronic kidney disease, potentially improving energy, muscle strength, and sexual function.
What could go wrong
This is a small, early-phase study with only 20 participants, so results may not apply to everyone. Oral testosterone may have side effects like liver strain or blood pressure changes, and it is not a cure.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for KIDNEY DISEASE, CHRONIC are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Saint Louis Univeristy
RECRUITINGSt Louis, Missouri, 63104, United States
Contact